secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tvardi Therapeutics, Inc. (TVRD)
CIK:        0001346830
Form:       8-K
Filed at:   2025-11-19T23:59:59+00:00
Accession:  0001104659-25-113901
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tvardi Therapeutics posts updated corporate presentation on Nov 19, 2025; full details unavailable
--------------------------------------------------------------------------------

- Corporate presentation is available on company's website as of November 19, 2025.
- Exhibit 99.1 only contains header 'Overview November 2025' with no specific data provided in filing excerpt.
- No financial or operational updates, guidance changes, or material events are disclosed in the available text.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1346830/000110465925113901/0001104659-25-113901-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1346830/000110465925113901/tm2531635d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-113901

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer